Plastic surgery is increasingly involved in addressing these needs across regenerative, aesthetic, and reconstructive domains
GLP-1 RAs = glucagon-like peptide-1 receptor agonists GLP-1/GIPRAs = dual glucagon-like peptide-1 / glucose-dependent insulinotrophic peptide receptor co-agonists ANZCAs latest clinical practice recommendations were updated and released in April 2025 here are the key changes you need to know
It can be inconvenient and uncomfortable, but it is often manageable
PMID: 9879640 | doi:10.1080/004982598238976 Hansen TK et al
Compounded drugs can be important for overcoming shortages or meeting unique patient needsbut compounders should not try to compound drugs in a way that circumvents FDA's approval process." 1 What Specific Violations and Commercial Risks Has the FDA Identified
Cangul IT, Gul NY, Topal A, Yilmaz R